AI assistant
Sending…
IRADIMED CORP — Director's Dealing 2025
Apr 4, 2025
32324_dirs_2025-04-04_a3903bb5-2f22-4c18-a6c4-518aa932548f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2024-12-07
Reporting Person: HAWKINS JAMES B (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-12-07 | Common Stock | M | 1196 | — | Acquired | 33545 | Direct |
Footnotes
F1: On December 10, 2024, the reporting person timely filed a Form 4, which inadvertently overstated in column 5 the number of shares of Iradimed Corporation (the "Issuer") common stock directly owned by the reporting person following the reported transaction. No transactions regarding the Issuer's securities were omitted. This inadvertent overstatement has been corrected in this amended filing.
More from IRADIMED CORP
Interim / Quarterly Report
2026
May 1
Annual Report
2026
Apr 30
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Feb 13
Regulatory Filings
2026
Feb 10
Major Shareholding Notification
2026
Feb 10
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 21
Director's Dealing
2026
Jan 13
Director's Dealing
2026
Jan 6